Categories
Health

Denmark says it’s completely stopping use of the AstraZeneca vaccine.

Denmark became the first country on Wednesday to plan to permanently stop administration of the AstraZeneca vaccine a month after it stopped using it after reports that a small number of recipients had developed a rare but serious bleeding disorder.

The country’s health authority director-general Soeren Brostroem said Denmark could stop using the vaccine as the pandemic was under control and it could rely on two other vaccines from Pfizer and Moderna.

The Danish announcement is another setback for the AstraZeneca shot, which is easy to store and relatively cheap, and should serve as the basis for vaccination campaigns around the world.

The country initially stopped using the vaccine on March 11, along with Iceland and Norway. Several other European countries including France, Germany and Italy followed suit last month.

The European Union’s Medicines Agency, the European Medicines Agency, later recommended countries continue to use the vaccine, saying its benefits far outweighed the potential risks for most people.

Last week, the European regulator listed blood clots as a possible very rare side effect of the vaccine.

Several countries that suspended and resumed use of the vaccine have since announced that they will discontinue use in younger people. The UK, which has given around 20 million AstraZeneca doses, said it would offer alternative vaccines to people under 30.

“Based on the scientific evidence, our overall assessment is that there is a real risk of serious side effects associated with using AstraZeneca’s Covid-19 vaccine,” said Danish health official Dr. Brostroem in a statement. “We have therefore decided to remove the vaccine from our vaccination program.”

“If Denmark were in a completely different situation, for example in the midst of a violent third outbreak and a health system under pressure,” he added, “then I would not hesitate to use the vaccine, even if it were rare.” but serious complications related to its use. “

Danish health officials said they might reintroduce the AstraZeneca vaccine “if the situation changes”.

Public health officials have warned that stopping vaccine delivery like AstraZeneca or Johnson & Johnson could do more harm than good. They find that out of seven million people in the United States who were vaccinated with the Johnson & Johnson single-dose vaccine, six women had developed the rare blood clots – fewer than one in a million. It is not yet known if the vaccine had anything to do with the clots, but even if it does, the risk is lower than being struck by lightning in any given year (one in 500,000).

Denmark, with a population of 5.8 million, managed to contain the pandemic better than its neighbor Sweden or many other European countries. As of Wednesday, Denmark had recorded 2,447 deaths related to Covid.

Nearly a million people in the country have received at least a first dose of a vaccine, 77 percent of them from Pfizer, according to the Danish Serum Institute. Around 15 percent received an initial dose of the AstraZeneca vaccine before authorities stopped using it last month, and the remaining 8 percent received the Moderna vaccine.

The country’s health officials said people who received a first dose of the AstraZeneca vaccine will be offered a different vaccine for their second dose.

Jasmina Nielsen contributed to the reporting.

Categories
World News

AstraZeneca Vaccine Beneath Extra Scrutiny After Denmark Demise

Denmark reported on Saturday that after receiving the AstraZeneca Covid-19 vaccine, two people suffered cerebral haemorrhage, one of whom died. The Danish Medicines Agency said it was looking to see if the disease was a possible side effect.

A spokesman for the capital region of Denmark confirmed the death, and the Danish news agency Ritzau reported that the other person, a civil servant in her thirties, was seriously ill.

Millions of people in dozens of countries have received the AstraZeneca Covid-19 vaccine with few reports of side effects. However, the European Medicines Agency, the continent’s top medicines agency, carried out a review after several countries stopped using the vaccine. On Thursday, the agency said it thought the vaccine was safe, although it would continue to look out for links to blood disorders. It was determined that any threat would be very minor and that the gunfire would prevent far more deaths than they could cause.

Recent blood clots and abnormal bleeding in a small number of vaccine recipients in European countries raised safety issues and resulted in suspensions. This resulted in a disruptive pause in vaccination campaigns this week, although some European countries entered a third wave of infections.

“At the moment we are investigating whether this is exactly the same clinical picture with multiple blood clots, low platelet counts and bleeding,” said Tanja Erichsen, director of the Danish Medicines Agency, in a radio interview with the Danish national broadcaster DR.

“We prioritize reports of suspected serious side effects like these and investigate them thoroughly to determine whether there is a possible link to the vaccine,” Ms. Erichsen said on Twitter on Saturday. “We are in the process of dealing with the two specific cases.”

This is the second death in Denmark after a person received the AstraZeneca vaccine. Norway is investigating the deaths of two people who received the vaccine.

Denmark has suspended the use of AstraZeneca until Thursday, despite assurances from the European Medicines Agency. Other Scandinavian countries and Finland have made similar decisions. However, some European countries, including France and Germany, have resumed recording.

Part of the continued caution is due to preliminary results from medical experts in Norway and Germany, which suggest a possible link between the vaccine and the extremely rare blood disorders. The German experts said the sinus or cerebral vein thrombosis, which Germans suffered 13 days after receiving the vaccine, was caused by an immune system reaction they believe may be related to the shot. They did not publish detailed data, but planned to present their results to The Lancet.

AstraZeneca didn’t immediately comment on the claims on Friday.

Dr. James Bussel, an expert in platelet disorders and professor emeritus at Weill Cornell Medicine, said the occurrence of abnormal clotting and low platelets in people under the age of 50 was unusual. He found that researchers in Europe had identified antibodies produced by the immune system – possibly in a highly unusual response to the vaccine – that may have activated platelets and triggered a cascade of abnormal clotting and bleeding.

Researchers in Germany and Norway will continue their research. In Germany, where the vaccine is being re-administered, doctors are now warning anyone who receives an AstraZeneca shot to see a doctor immediately if they have a headache, dizziness, or blurred vision more than three days later. They said the problems could very likely be addressed if identified in time.

Categories
Business

Denmark suspends use of AstraZeneca Covid vaccine

The Oxford-AstraZeneca Covid vaccine.

Karwai Tang | Getty Images

LONDON – Denmark announced on Thursday that it would temporarily stop using the coronavirus vaccine developed by AstraZeneca and Oxford University.

The Danish health authority said it would temporarily suspend the use of the shot in its vaccination program “following reports of severe cases of blood clots in people vaccinated with AstraZeneca’s COVID-19 vaccine”.

“With this in mind, the European Medicines Agency has launched an investigation into the AstraZeneca vaccine. One report relates to a death in Denmark. It cannot currently be concluded whether the vaccine is related to the blood clots.” Authority said in a statement.

No information was provided about the number of reports of blood clots or where they came from.

The announcement comes after a similar move in Austria earlier this week, where authorities are investigating one person’s death and another person’s illness after receiving doses of the vaccine.

AstraZeneca’s shares in the London market were down 2.4% on Thursday morning. Oxford University would not comment on the announcement when contacted by CNBC.

An AstraZeneca spokesman said the company was aware of a statement by the Danish health authority that it is investigating possible adverse effects of the vaccine.

“Patient safety is a top priority for AstraZeneca. Regulators have clear and strict standards of efficacy and safety for approving new drugs, including the COVID-19 vaccine AstraZeneca. The vaccine’s safety has been thoroughly investigated in Phase III clinical trials. Review data confirms the vaccine is generally well tolerated, “AstraZeneca said in a statement to CNBC.

Søren Brostrøm, director of the National Health Department in Denmark, insisted that the 14-day suspension was a precautionary measure during the investigation.

“It is important to emphasize that we did not decide against the AstraZeneca vaccine, we are deferring it. There is good evidence that the vaccine is both safe and effective. But both we and the Danish Medicines Agency need to respond Reports of possible serious side effects from both Denmark and other European countries, “he said.

Austria concerns

The Austrian health authorities stopped using batch ABV5300 of the AstraZeneca vaccine after a person was diagnosed with multiple thrombosis (formation of blood clots in blood vessels) and died 10 days after vaccination. Another person was hospitalized with pulmonary embolism after vaccination.

“The latter is now recovering,” said the European Medicines Agency on Wednesday.

However, the EMA added that “there is currently no evidence that vaccination caused these conditions that are not listed as side effects with this vaccine.”

The EMA found that the same batch of ABV5300 was shipped to 17 EU countries and comprised 1 million doses of the vaccine.

“Some EU countries have also suspended this batch as a precautionary measure while a full investigation is in progress. Although a quality defect is considered unlikely at this point, the batch quality will be investigated,” said the EMA.

It added that its safety committee was reviewing the issue and “investigated the cases reported with the batch, as well as all other cases of thromboembolic events and other blood clot-related conditions post-vaccination.”

“The information available so far shows that the number of thromboembolic events in vaccinated people is no higher than in the general population.”

As of March 9, “22 cases of thromboembolic events have been reported among the 3 million people vaccinated with the AstraZeneca COVID-19 vaccine in the European Economic Area,” the EMA said.

Trust in the UK and the EU

In late clinical studies, the AstraZeneca-Oxford shot was found to have an average of 70% effectiveness in protecting against the virus. A recent study by Oxford researchers found that the Covid vaccine was 76% effective at preventing symptomatic infection for three months after a single dose and that the effectiveness rate actually increased with a longer interval between the first and second dose.

The AstraZeneca-Oxford vaccine is widely used in the launch of vaccination in the UK and the European Union.

The UK has so far vaccinated over 22 million people with a first dose of a coronavirus vaccine and is currently only using the AstraZeneca and Pfizer-BioNTech shot.

Categories
Business

Denmark needs to construct a renewable power island within the North Sea

The facility will be located in waters off the coast of Jutland.

ah_fotobox | iStock | Getty Images

Denmark will move ahead with its plans to build a huge man-made island in the North Sea that will act as a major renewable energy hub and cost billions of dollars to develop.

The Danish Energy Agency, which is part of the government’s Ministry of Climate, Energy and Utilities, said Thursday the project would be part of a public-private partnership, with the Danish state holding a majority stake.

The scope of the project, which will be located in waters 80 kilometers off the coast of Jutland, the large peninsula with mainland Denmark, is considerable.

In the first phase, with an output of 3 gigawatts (GW), around 200 offshore wind turbines are supplied with electricity to the hub, which is then distributed to the surrounding countries via the grid.

In the future, the hub’s capacity could be expanded to 10 GW. According to the Danish authorities, this would be enough to supply 10 million households in Europe with electricity. Depending on its final capacity, the island will cover an area between 120,000 and 460,000 square meters.

The estimated cost of building the artificial island, 10 GW capacity and the necessary transmission network is 210 billion Danish kroner (33.97 billion US dollars).

“The energy hub in the North Sea will be the largest construction project in Danish history,” said Danish climate minister Dan Jørgensen in a statement.

“It will go a long way towards realizing the enormous potential for European offshore wind and I look forward to our future collaboration with other European countries,” he added.

The project is now moving forward and the Danish climate department will start discussions with potential investors from the private sector. At the political level, the terms of the tender are negotiated, new legislation is passed and environmental impact assessments are carried out.

In addition to the artificial island, a second energy hub of 2 GW is planned for the Baltic Sea island of Bornholm.

Denmark is a pioneer when it comes to offshore wind projects. The world’s first offshore wind farm in waters near the Danish island of Lolland was commissioned in 1991 by Orsted – the company formerly known as DONG Energy. Other Danish companies like the turbine manufacturer Vestas are important players in wind energy.

Looking ahead, the European Union, of which Denmark is a part, wants its offshore wind capacity to reach 60 GW by 2030 and 300 GW by the middle of the century.

Categories
Entertainment

Pixar’s ‘Soul’ Has a Black Hero. In Denmark, a White Actor Dubs the Voice.

COPENHAGEN – Like most of their peers around the world, Danish film critics first hailed “Soul,” Pixar’s first animated feature film that enthusiastically focused on black characters and African American culture, and praised the sensitive, joyful portrayal of a jazz musician on a quest for one meaningful life.

The film has been described as “a miracle” by one reviewer in Denmark and “beautiful and life-giving” by another.

What the Danish press, by and large, initially failed to focus on was the race of the characters. However, that changed after the film was released on December 25th, when the knowledge spread that the Danish-language version had been dubbed mainly by white actors. This is also the case in many other European-language versions of “Soul”.

While the movie’s voice-over casting is barely public knowledge in most countries, in Portugal more than 17,000 have signed a petition asking Pixar to redesign the local edition with color cast members. “This film is not just another film, and representation is important,” the petition said.

Joe Gardner, the main character in “Soul”, is Pixar’s first black protagonist. The studio took steps to accurately portray African American culture by hiring Kemp Powers as co-director and establishing a “cultural trust” to ensure the authenticity of the story. Actor Jamie Foxx, who voices Joe in the English-language original, told the New York Times: “Playing the first black lead in a Pixar movie feels like a blessing.” (To make matters worse, due to various plot machinations, Joe is voiced by Tina Fey for a decent portion of the film, a decision that has generated some criticism.)

In the Danish version, Joe is voiced by Nikolaj Lie Kaas, who is white. When the national newspaper Berlingske interviewed scholars and activists who expressed their disappointment with the fact that the casting was an example of structural racism, a heated controversy erupted which led Lie Kaas to issue an explanation as to why he was accepted the role.

“My position in relation to any job is very simple,” he wrote on Facebook. “Let the man or woman who can do the job the best they can get the job.”

Asta Selloane Sekamane, one of the activists who criticized the casting in the Berlingske article, said in an interview that no one could say there wasn’t enough black talent to star because color actors were hired to cast some of the votes express smaller parts. “It can’t be the constant excuse, this idea that we can’t find people who meet our standards,” she added. “It’s an invisible bar that connects qualification with white.”

Mira Skadegard, a professor at Aalborg University in Denmark who studies discrimination and inequality, said resistance to allegations of structural racism was not surprising. “In Denmark we have a long history of denial about racism and a deep investment in the ideal of equality,” she said.

“We don’t really see this as a criticism of institutions and structures. We see it as a criticism of who we are, ”she added.

In Denmark and Portugal, dubbing is generally reserved for animation and children’s programs. In other European countries, including France, Germany, Italy, and Spain, most mainstream foreign films are dubbed and the practice is viewed as an art in its own right – one based on practitioners’ ability to be inconspicuous.

“The best dubbing should go completely undetected,” said Juan Logar, a leading Spanish dubbing director and voice actor.

“My job is to find the voice that best fits the original,” said Logar. “Black, white, Asian, it doesn’t matter.”

The German voice actor Charles Rettinghaus expressed a similar feeling. In his 40-year career, he has been the voice of actors such as Jean-Claude Van Damme and Javier Bardem, but he said he feels a special connection with Jamie Foxx, who he has featured in more than 20 films, including the German version of “soul”.

Despite being white, Rettinghaus said he didn’t feel compelled to abstain from any black roles, adding that the same opportunities should apply to actors of all races. “It doesn’t matter if you’re black, you should and are allowed to synchronize everything,” he said. “Why shouldn’t you play a white actor or an Indian or an Asian?”

Kaze Uzumaki, a black colleague from Rettinghaus, said it was more complicated. Uzumaki names the character of Paul in “Soul” and has lent his voice to the German versions of dozens of other American films and TV series. Almost without exception, his roles were originally played by color actors.

“I really didn’t like it at first,” he said. “But I thought I would feel more comfortable doing the role than many other white colleagues who don’t have a good command of the English language and can’t really tell what a black person sounds like.”

Uzumaki said he called color doctors on hospital shows only to learn from the director that he sounded “too educated.”

“They don’t even realize that they are racist,” said Uzumaki. “But every time a director says something like, ‘No, you sound too polished. You know how to talk, right? ‘I feel like I’ve been hit in the face with a stick. “

Discrimination is often double-edged. Ivo Chundro, a Dutch color actor who named the role of Paul in “Soul” for distribution in the Netherlands, said: “The directors will only cast white actors for white parts and tell the color actors: ‘No, your voice is not’ . t know enough. ‘”

Some directors say demographics limit choices. “We don’t have a second generation of immigrants in Spain,” said Logar. “Except for a few very young children, there aren’t many black actors born here who speak Spanish without an accent.”

Color actors like Chundro and Uzumaki claim that these directors just don’t look too closely. But there are signs that things are gradually changing. In 2007 a voice actor in France told actress Yasmine Modestine that her voice was wrong for a role because she was a mixed race. Following her complaint, the French Equal Opportunities Commission examined the dubbing industry as a whole and found a culture of prejudice and stereotypes.

Since then, the possibilities for voice actors of color have expanded there. Fily Keita, who voiced Lupita Nyong’o in the French-language version of “Black Panther”, said that she didn’t feel held back as a black actor working in the industry. She has also cast roles that were originally played by white actresses such as Amanda Seyfried and Jamie-Lynn Sigler.

“I love to dub because it’s a space of freedom,” she said. “Where you are not limited by your looks.”

Chundro, the Dutch actor, said the Black Lives Matter movement was starting to shift the conversation around race and representation in the Netherlands. He cited a demonstration in Amsterdam in June to open eyes to ongoing racism.

“I used to have a lot of discussions about racism that people just didn’t understand,” said Chundro. But the protest “was like a bandage torn from a wound and it’s been a lot easier to talk about since then,” he added.

With that greater awareness, there are more possibilities, he said. “There’s more work out there and I’m getting a lot more busy.”

Sekamane, the Danish activist, also attributed changes in attitudes to the movement. “I’m 30 years old and all my life I’ve been told that racism is on my mind,” she said. “It wasn’t until last year that the conversation changed thanks to Black Lives Matter.”